Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers

75Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Drug resistance hinder most cancer chemotherapies and leads to disease recurrence and poor survival of patients. Resistance of cancer cells towards apoptosis is the major cause of these symptomatic behaviours. Here, we showed that isoquinoline alkaloids, including liensinine, isoliensinine, dauricine, cepharanthine and hernandezine, putatively induce cytotoxicity against a repertoire of cancer cell lines (HeLa, A549, MCF-7, PC3, HepG2, Hep3B and H1299). Proven by the use of apoptosis-resistant cellular models and autophagic assays, such isoquinoline alkaloid-induced cytotoxic effect involves energy- and autophagy-related gene 7 (Atg7)-dependent autophagy that resulted from direct activation of AMP activated protein kinase (AMPK). Hernandezine possess the highest efficacy in provoking such cell death when compared with other examined compounds. We confirmed that isoquinoline alkaloid is structurally varied from the existing direct AMPK activators. In conclusion, isoquinoline alkaloid is a new class of compound that induce autophagic cell death in drug-resistant fibroblasts or cancers by exhibiting its direct activation on AMPK.

Cite

CITATION STYLE

APA

Law, B. Y. K., Mok, S. W. F., Chan, W. K., Xu, S. W., Wu, A. G., Yao, X. J., … Wong, V. K. W. (2016). Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers. Oncotarget, 7(7), 8090–8104. https://doi.org/10.18632/oncotarget.6980

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free